Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cass

Showing results (231-240 of 304) with videos related to

Pageof 31
Sort By:
Cancer Chemotherapy and Pharmacology|May 27, 2008
Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell culturesAdam N Elwi, Vijaya L Damaraju, Michelle L Kuzma, et al.
Molecular Pharmacology|October 16, 2004
Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide ribosideVijaya L Damaraju, Frank Visser, Jing Zhang, et al.
The Journal of Biological Chemistry|May 15, 2002
Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocationSylvia Y M Yao, Amy M L Ng, Mark F Vickers, et al.
The Journal of Membrane Biology|June 25, 2003
Coupling of CFTR-mediated anion secretion to nucleoside transporters and adenosine homeostasis in Calu-3 cellsA J Szkotak, A M L Ng, S F P Man, et al.
The Journal of Biological Chemistry|March 24, 2007
Residues 334 and 338 in transmembrane segment 8 of human equilibrative nucleoside transporter 1 are important determinants of inhibitor sensitivity, protein folding, and catalytic turnoverFrank Visser, Lijie Sun, Vijaya Damaraju, et al.
Cancer Research|October 10, 1998
Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell linesJ R Mackey, R S Mani, M Selner, et al.
The Journal of Biological Chemistry|October 5, 2001
Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugsM Sundaram, S Y Yao, J C Ingram, et al.
American Journal of Physiology. Cell Physiology|November 8, 2001
Regulation of K(+) current in human airway epithelial cells by exogenous and autocrine adenosineA J Szkotak, A M Ng, J Sawicka, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|November 21, 2002
Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiaeMark F Vickers, Rakesh Kumar, Frank Visser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancerSambasivarao Damaraju, David Murray, Jennifer Dufour, et al.
Pageof 31

Showing results (231-240 of 304) with videos related to

Sort By:
Pageof 31
Cancer Chemotherapy and Pharmacology|May 27, 2008
Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell culturesAdam N Elwi, Vijaya L Damaraju, Michelle L Kuzma, et al.
Molecular Pharmacology|October 16, 2004
Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide ribosideVijaya L Damaraju, Frank Visser, Jing Zhang, et al.
The Journal of Biological Chemistry|May 15, 2002
Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocationSylvia Y M Yao, Amy M L Ng, Mark F Vickers, et al.
The Journal of Membrane Biology|June 25, 2003
Coupling of CFTR-mediated anion secretion to nucleoside transporters and adenosine homeostasis in Calu-3 cellsA J Szkotak, A M L Ng, S F P Man, et al.
The Journal of Biological Chemistry|March 24, 2007
Residues 334 and 338 in transmembrane segment 8 of human equilibrative nucleoside transporter 1 are important determinants of inhibitor sensitivity, protein folding, and catalytic turnoverFrank Visser, Lijie Sun, Vijaya Damaraju, et al.
Cancer Research|October 10, 1998
Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell linesJ R Mackey, R S Mani, M Selner, et al.
The Journal of Biological Chemistry|October 5, 2001
Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugsM Sundaram, S Y Yao, J C Ingram, et al.
American Journal of Physiology. Cell Physiology|November 8, 2001
Regulation of K(+) current in human airway epithelial cells by exogenous and autocrine adenosineA J Szkotak, A M Ng, J Sawicka, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|November 21, 2002
Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiaeMark F Vickers, Rakesh Kumar, Frank Visser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancerSambasivarao Damaraju, David Murray, Jennifer Dufour, et al.
Pageof 31